Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06968494 · ClinicalTrials.gov registry record · NA
Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction
A NA study of Erectile Dysfunction Following Radical Prostatectomy, sponsored by Comphya.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06968494 is a NA study of Erectile Dysfunction Following Radical Prostatectomy that is actively recruiting participants, run by Comphya. The registered enrollment target is 20 participants, below the 211-participant average among 4 other Erectile Dysfunction Following Radical Prostatectomy trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06968494, a NA study of Erectile Dysfunction Following Radical Prostatectomy, is actively recruiting participants, sponsored by Comphya.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to assess if a new device is safe to use as a potential treatment for erectile dysfunction following radical prostatectomy. The main questions it aims to answer are: * Is the device safe? * Does the device works well? Are the participants satisfied with the device? Participants will be implanted with the device during the ongoing prostatectomy surgery and will be asked to complete the following tasks during 6 months follow-up: * Come to the hospital for follow-up visits, * Complete questionnaires, * Activate the device every day, * Measure erection hardness. Researchers will compare an implanted group (participants having the device) with a control group (participants not having the device) to see if the device works well.
Conditions Studied
Interventions
- DEVICE Activation of pro-erectile nerves within the pelvic plexus
Study Locations (1)
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-06-05 |
| Est. Completion | 2027-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06968494
The ClinicalTrials.gov registry entry for NCT06968494 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 211-participant average among 4 other Erectile Dysfunction Following Radical Prostatectomy trials with a reported enrollment target (91% lower). The listed sponsor is Comphya, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Erectile Dysfunction Following Radical Prostatectomy appearing as the primary indexed condition, and to 1 intervention - of which Activation of pro-erectile nerves within the pelvic plexus is the first listed.
NCT06968494 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06968494 about?
NCT06968494 is a clinical study titled "Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction". The goal of this clinical trial is to assess if a new device is safe to use as a potential treatment for erectile dysfunction following radical prostatectomy. The main questions it aims to answer are: * Is the device safe? * Does the device works well? Are the participants satisfied with the devic...
What is the current status of trial NCT06968494?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-06-05. Estimated completion is 2027-04.
What conditions does trial NCT06968494 study?
This clinical trial studies the following conditions: Erectile Dysfunction Following Radical Prostatectomy.
What interventions are being tested in trial NCT06968494?
The interventions under investigation include: Activation of pro-erectile nerves within the pelvic plexus (DEVICE).
Who is sponsoring clinical trial NCT06968494?
This trial is sponsored by Comphya, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06968494 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Erectile Dysfunction Following Radical Prostatectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RECRUITING · NA
-
Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy
RECRUITING · NA
-
Low Intensity Shockwave Therapy for Erectile Dysfunction
ACTIVE NOT RECRUITING · NA
-
Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.